Abstract
Objective: To compare the branch morphology and short-term outcome of endovascular aneurysm repair using custom-made vs standardized multi-branched thoracoabdominal stent grafts. Methods: Custom-made stent grafts (CSG) with patient-specific cuff locations were compared with standardized stent grafts (SSG) with uniform cuff locations. Data on patient demographics, aortic morphology, component use, and outcome were collected prospectively. Final branch length (cuff to target artery orifice) and branch angle (cuff orientation to target artery orientation) were determined using 3-D reconstruction of computed tomography angiograms (CTA). Results: Since January 2008, 24 patients underwent endovascular repair using 13 CSG (10 in 2008, 3 in 2009) and 11 SSG (1 in 2008, 10 in 2009). Two SSG patients were excluded from analysis: one has yet to undergo CTA, the other had crossed renal branches due to problems traversing a previously reconstructed aortic arch. All stent grafts were implanted successfully. There were no perioperative deaths. All branches were patent on the initial postoperative CTA. There were no statistically significant differences between the CSG and SSG groups in terms of patient demographics, procedural details (operation length, fluoroscopy time, contrast volume, blood loss), or mean branch length and angle (Table).Table 1Comparison of branch morphology between custom-made and standardized stent graftsTarget arteryMean branch angle (degrees)Mean branch length (mm)CSG (sd)SSG (sd)p-valueCSG (sd)SSG (sd)p-valueCA (n = 22)14.5 (13.3)20.4 (11.2)0.2925.1 (15.7)20.2 (8.1)0.40SMA (n = 22)25.6 (18.6)17.3 (17.6)0.3127.0 (12.5)19.6 (3.0)0.10RRA (n = 21)25.3 (19.9)25.0 (14.6)0.9623.5 (11.3)24.9 (11.6)0.78LRA (n = 21)26.1 (23.0)28.7 (25.0)0.8125.3 (8.4)27.3 (10.6)0.64All (n = 86)22.8 (19.0)22.9 (17.6)0.9825.3 (12.0)23.0 (9.1)0.33 Open table in a new tab Conclusions: The substitution of SSG for CSG had no effect on the complexity of the procedure, the final branch morphology, or the perioperative outcome. The availability of an off-the-shelf SSG will broaden the application of endovascular TAAA repair by eliminating manufacturing delays.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.